Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Asset Writedowns and Impairment (2020 - 2026)

SkinHealth Systems has reported Asset Writedowns and Impairment over the past 6 years, most recently at $3.6 million for Q4 2025.

  • Quarterly Asset Writedowns and Impairment fell 33.0% to $3.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.2 million through Dec 2025, down 74.26% year-over-year, with the annual reading at $7.2 million for FY2025, 74.26% down from the prior year.
  • Asset Writedowns and Impairment was $3.6 million for Q4 2025 at SkinHealth Systems, up from $2.1 million in the prior quarter.
  • Over five years, Asset Writedowns and Impairment peaked at $20.7 million in Q3 2024 and troughed at -$6.8 million in Q4 2023.
  • The 5-year median for Asset Writedowns and Impairment is $457000.0 (2021), against an average of $2.6 million.
  • The largest YoY upside for Asset Writedowns and Impairment was 4571.43% in 2022 against a maximum downside of 4313.54% in 2022.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $96000.0 in 2021, then crashed by 4313.54% to -$4.0 million in 2022, then plummeted by 66.92% to -$6.8 million in 2023, then surged by 179.04% to $5.3 million in 2024, then crashed by 33.0% to $3.6 million in 2025.
  • Per Business Quant, the three most recent readings for SKIN's Asset Writedowns and Impairment are $3.6 million (Q4 2025), $2.1 million (Q3 2025), and $1.3 million (Q2 2025).